Tag Archives: ataluren

Drug company donates £1,000 to ANUK

Posted on February 17, 2015 by

A global biopharmaceutical company has provided a donation to ANUK for which we are extremely grateful. PTC Therapeutics is the company that discovered and is developing ataluren for the treatment of disorders due to a genetic nonsense mutation. Approximately 20% of patients … Continue reading →

Rate this:

Posted in ANUK news, Fundraising, Research | Tagged , , , | Leave a comment

Cure for aniridia under spotlight

Posted on January 14, 2014 by

A new study has suggested potential eyedrop therapy for aniridia. Is the hype justified and what are the details? Aniridia is a genetic abnormality caused by mutations in the so-called ‘Master Regulator’ gene for eye development, PAX6.  Because PAX6 is … Continue reading →

Rate this:

Posted in Medical staff talking, Research | Tagged , , , | 7 Comments